Bundamedik Healthcare System

What Bundamedik Healthcare System does

Bundamedik Healthcare System (BMHS) operates an integrated Indonesian healthcare ecosystem anchored on the RS Bunda Group hospital network. As of mid-2024 the company ran 10 hospitals across Jakarta, Depok, Padang, Palembang, Bekasi, Ciputat, Denpasar, and Surabaya, with women-and-children services contributing 51% of hospital revenue in 9M25 and complex specialty procedures making up the balance. Specialized subsidiaries extend the care continuum: Morula IVF Indonesia (10-12 fertility clinics, domestic IVF pioneer since 1997), Diagnos Laboratorium Utama (25 diagnostic and genomic testing facilities), Bunda Global Pharma, BMHS Diklat Indonesia (workforce training), Bunda Homecare, and the OneBunda digital platform that links patients across services. Underlying clinical capabilities include robotic surgery (pioneered domestically in 2012 with over 800 cumulative procedures; Generation 2 system launched in 2025), a 31-bed Neonatal Intensive Care Unit with a Family Integrated Care program, six kidney transplants completed with a 100% success rate, and genomic laboratory testing.

Name

Bundamedik Healthcare System

Legal name

PT Bundamedik Tbk

Website

https://bmhs.co.id

Company type

Public

Founded year

1973

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Bundamedik Healthcare System operates an integrated Indonesian healthcare ecosystem spanning 10 hospitals, 10+ IVF clinics, and 25 laboratories. Listed on the IDX since 2021, it serves over 1 million patients annually through women, children, and fertility care services.

Ownership category

akta.pro rank

Headquarters

HQ city

Jakarta Pusat

HQ country

Indonesia

HQ region

Asia

Offices11 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Hospital Services (RSU/RSIA): Inpatient and outpatient hospital services across the RS Bunda Group network. Contributes the majority of consolidated revenue. Services include general and specialized medical care, maternity and child health, complex procedures, and executive health services.
2. Fertility Services (Morula IVF Indonesia): In Vitro Fertilization and assisted reproductive technology services. Morula operates 10+ IVF clinics across Indonesia and contributes through fresh cycles, with 11% QoQ growth in Q3 2025. Jinxin Fertility Group holds a significant equity stake.
3. Diagnostic Laboratory (Diagnos Laboratorium): Laboratory and genomic testing services. Diagnos recorded 12% YoY volume growth in Q3 2025, with genomic services growing 37% YoY in 2024. Non-COVID lab tests grew 43% YoY in Q1 2024.
4. Bunda Global Pharma (Pharmaceutical Distribution): Distribution of medicines and medical devices through the BMHS ecosystem. Includes pharmaceutical supply chain supporting hospital and clinic operations.
5. BMHS Diklat Indonesia (Training & Education): Healthcare workforce education and training services, including structured training programs and field practice for healthcare professionals. Partnerships with institutions like RS Bhayangkara Brimob and IPB University.
6. Emergency Response (ER) Services: Medical evacuation and emergency response services within the BMHS ecosystem.

Go-to-market motion2 records

Distribution channels7 records

Marketing channels10 records

Core offering

Bundamedik Healthcare System (PT Bundamedik Tbk) operates an integrated healthcare ecosystem in Indonesia spanning hospitals, IVF/fertility clinics, diagnostic laboratories, pharmaceutical distribution, healthcare training, and homecare services. The network includes the RS Bunda Group hospitals, Morula IVF Indonesia fertility clinics, and Diagnos Laboratorium clinics, supported by a digital platform (OneBunda) and transport-hub clinics.

Product overview

Bundamedik Healthcare System (BMHS) operates as an integrated healthcare ecosystem providing comprehensive family health services through a multi-brand portfolio. The core offering centers on RS Bunda Group hospital network (8+ hospitals specializing in women and children healthcare), supported by specialized subsidiaries including Morula IVF Indonesia (fertility services), Diagnos Laboratorium (diagnostic and genomic testing), and Bunda Homecare (home medical visits). Additional services span emergency response, pharmaceutical distribution, healthcare training, physiotherapy, and medical tourism. The ecosystem is unified through the OneBunda digital platform, enabling patients to access all services from pregnancy through elderly care. BMHS emphasizes Centers of Excellence in women and children health, fertility, and robotic surgery, complemented by preventive services like the transport hub-based Bunda Clinic.

Differentiator

Problem solved

Functional benefit

Brands

• OneBunda: Digital touchpoint application that allows patients to access all information and services within the BMHS ecosystem, from pregnancy programs to health services for parents and children
• Bunda Homecare
• Bunda Clinic MRT Dukuh Atas
• HealthConEx
• Center of Excellence (CoE)

Products and services

• RS Bunda Group Hospital Network Integrated hospital network providing general medical, emergency, surgical, maternal, pediatric, cardiac, dental, and specialist care across 10 hospitals in Indonesia.
• Morula IVF Indonesia Fertility treatment and reproductive medicine services including IVF, IUI, ICSI, PGT, andrology, and gynecological services across a network of 12 fertility clinics.
• Diagnos Laboratorium Network of 25 diagnostic laboratories providing clinical pathology, anatomic pathology, genomic testing, and preventive screening services to patients and clinicians.
• Bunda Homecare Home-based healthcare services including doctor and nurse home visits, home sample collection for laboratory testing, and home physiotherapy for recovering or chronic-care patients.
• Bunda Global Pharma Pharmaceutical distribution arm supplying medical products, equipment, and consumables to the BMHS hospital and clinic network.
• BMHS Diklat Indonesia Healthcare training and education programs for medical professionals, including clinical rotations, skills training, and continuing education in partnership with medical faculties.
• OneBunda Digital Platform Digital healthcare application enabling patients to book doctor appointments, access medical records, register for hospital and clinic services, and engage with BMHS healthcare offerings online.
• Bunda Clinic MRT Dukuh Atas Walk-in primary care and emergency clinic located at MRT Dukuh Atas transit station providing accessible healthcare to commuters and the general public.
• Bunda Executive Clinic Premium executive health screening and check-up service providing comprehensive medical examinations tailored for professionals and corporate clients.
• IRSI (Indonesian Reproductive Science Institute) Specialized reproductive science institute conducting fertility research, training, and advanced reproductive technology development.
• Sasana Mitra Bunda Fisioterapi Dedicated physiotherapy and rehabilitation services for patients requiring post-treatment, musculoskeletal, and recovery therapy.

Quantifiable outcome

• Net profit grew 950% QoQ in Q3 2025, with EBITDA margin increasing from 13% to 17%
• +7 more outcomes

Named customers8 records

Segments7 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature6 records

Partnerships

Eight partnerships are on record, tiered minor and core.

• PT MRT Jakarta (Perseroda)minorStrategic or Co-development Partner · 22 October 2025Collaboration to establish Bunda Clinic MRT Dukuh Atas, the first health clinic inside a Jakarta transport hub. The clinic brings preventive health services (vaccination, wellness, health checks) to urban commuters at the intersection of 4 major transportation modes. Also involves Government of DKI Jakarta and Dinas Kesehatan DKI Jakarta. Supports MRT Jakarta's vision for transit-oriented development as a healthy, productive, and inclusive public space.
• PT Industri Jamu Dan Farmasi Sido Muncul TbkminorStrategic or Co-development Partner · 8 February 2025Partnership to establish Gerai Sehat (Healthy Outlet) at RSU Bunda Margonda. This collaboration is part of the holistic approach of RS Bunda Group to support health innovation in Indonesia, combining modern medicine with traditional herbal medicine (jamu) for comprehensive family healthcare.
• IPB UniversityminorStrategic or Co-development Partner · 15 January 2025MoU for Tridharma (Higher Education Three Pillars): Education, Research, and Community Service. Collaboration covers biotechnology and biomedicine fields aligned with BMHS expertise, and opens opportunities for joint research, education, and workforce capacity building. The partnership builds on an existing collaboration that started in 2022 and continues to develop.
• Jinxin Fertility Group Limited (JXR)coreStrategic or Co-development Partner · 1 April 2024Strategic investment partnership where JXR became a significant shareholder of PT Morula Indonesia (Morula), BMHS's IVF subsidiary. JXR is a leading assisted reproductive services and Women & Children specialty healthcare group in China and the US, listed on Hong Kong Stock Exchange since June 2019. The partnership aims to leverage mutual expertise to capitalize on the untapped IVF market potential in Indonesia and Southeast Asia, combining JXR's 70+ years of medical industry experience with Morula's 27+ years of market leadership in Indonesia.
• PT Sinar Medika Langgeng (Sinar Mas Land Ecosystem)coreStrategic or Co-development PartnerStrategic collaboration for development of a modern hospital in the Education, Technology, and Health International Special Economic Zone (KEK ETKI) in Banten, BSD City. Signed at the Indonesian Ministry of Health and aligned with government vision to improve healthcare access, quality, and resilience while reducing medical tourism abroad. The partnership will encompass research, digital innovation (telemedicine), and medical competency development.
• RS Bhayangkara BrimobminorStrategic or Co-development PartnerStrategic collaboration between BMHS Diklat Indonesia (BDI) and RS Bhayangkara Brimob focused on healthcare workforce development. The program covers structured and applicable health professional education and training aligned with evolving healthcare industry needs, through integrated learning and field practice to drive consistent improvement in healthcare service quality.
• Government of DKI Jakarta / Dinas Kesehatan DKI JakartaminorStrategic or Co-development PartnerCollaboration with provincial government and health department for community health initiatives including Gebyar Kesehatan during Jakarta Anniversary (HUT DKI), free health checks at Rusunawa Rawa Bebek serving 300+ residents, and support for urban wellness programs.
• Indonesian Medical Association (PB IDI) / IDI DepokminorStrategic or Co-development PartnerBMHS collaborates with IDI (Indonesian Medical Association) and local IDI branches for professional healthcare standards, medical education, and community health initiatives, including participation in medical events and professional development programs.

Scale indicators22 records

Recent moves14 records

Expansion highlights7 records

Direct peers

• Medikaloka Hermina (PT Medikaloka Hermina Tbk): IDX:HEAL — Indonesian hospital network historically anchored in mother-and-child services, now broader. The most direct competitor to BMHS's Women & Children CoE focus and similar specialty positioning.
• Mitra Keluarga Karyasehat (PT Mitra Keluarga Karyasehat Tbk): Indonesian listed hospital network (IDX:MIKA) with a similar "women-and-family friendly" positioning and comparable hospital footprint. A closest direct comp on segment mix, mid-tier pricing, and IDX-listed disclosure profile.
• Prodia Widya Husada (PT Prodia Widya Husada Tbk): Indonesia's largest clinical laboratory network (IDX:PRDA). The closest listed comparable to BMHS's Diagnos Laboratorium subsidiary, sharing customer base, genomic testing exposure, and IDX disclosure profile.
• Jinxin Fertility Group (锦欣生殖, 1951.HK): HKEX-listed IVF group that became a significant shareholder of BMHS's Morula subsidiary in 2024. Direct IVF-services peer in the same regional market and explicit strategic partner and equity holder in Morula.
• Siloam International Hospitals (PT Siloam International Hospitals Tbk): Indonesia's largest private hospital operator (IDX:SILO), running 40+ hospitals across the country. Directly comparable as an Indonesian listed multi-hospital network competing for the same patients, specialists, and BPJS/JKN reimbursements as BMHS.

Broad incumbents

• Raffles Medical Group: SGX-listed integrated private healthcare provider in Singapore/China/Hong Kong. Comparable as an established Asian private healthcare platform with hospital + ancillary services breadth adjacent to BMHS's integrated ecosystem.
• IHH Healthcare Berhad: Malaysia-listed Asia-Pacific hospital giant operating Mount Elizabeth, Gleneagles, Pantai and Acibadem brands. Comparable as a premium multi-country hospital operator; represents the large-incumbent benchmark for cross-border hospital expansion.
• Bangkok Dusit Medical Services (BDMS): Thailand's largest private hospital network (SET:BDMS). Comparable as a Southeast Asian publicly listed hospital chain with strong medical-tourism positioning and a similar premium–mid-tier segmentation strategy.
• Bumrungrad Hospital: SET:BH — Thai premium hospital and a global benchmark for medical tourism and complex specialty care. Provides a relevant comp for BMHS's Indonesia Medical Tourism Board subsidiary and high-complexity CoE economics.
• Ramsay Sime Darby Health Care: Malaysia-based private hospital operator combining Ramsay Health Care's global hospital expertise with Sime Darby's regional presence. Comparable as an established Southeast Asian hospital competitor vying for premium-tier and medical-tourism patients.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCwj7zpkV8Ktjw8oCFfvw1Nw
• Facebookfacebook.com/bundamedik1973
• LinkedInlinkedin.com/company/bhms-bundamedikhealthservice
• Instagraminstagram.com/bmhs.id

Revenue estimate

Valuation estimate

Number of profiles

Profiles18 records

Subsidiaries21 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bundamedik Healthcare System